GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cian Healthcare Ltd (BOM:542678) » Definitions » 5-Year EBITDA Growth Rate

Cian Healthcare (BOM:542678) 5-Year EBITDA Growth Rate : 2.40% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cian Healthcare 5-Year EBITDA Growth Rate?

Cian Healthcare's EBITDA per Share for the six months ended in Mar. 2024 was ₹2.45.

During the past 12 months, Cian Healthcare's average EBITDA Per Share Growth Rate was -17.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -0.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cian Healthcare was 15.30% per year. The lowest was -23.50% per year. And the median was -3.70% per year.


Competitive Comparison of Cian Healthcare's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Cian Healthcare's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cian Healthcare's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cian Healthcare's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cian Healthcare's 5-Year EBITDA Growth Rate falls into.



Cian Healthcare 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Cian Healthcare  (BOM:542678) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Cian Healthcare 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cian Healthcare's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Cian Healthcare Business Description

Traded in Other Exchanges
N/A
Address
Vitthal Rao Shivarkar Road, Office No. 508-511, 5th Floor, Sacred World, Above Macdonald, Wanowrie, Pune, MH, IND, 411040
Cian Healthcare Ltd is a fully integrated pharmaceutical company. It is engaged in the research, development, and manufacturing of different forms of tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets. The company's portfolio comprises of gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotics, CNS, vitamins, and nutrient products. It operates in five sectors namely Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party. The majority of the revenue is generated from the Indian Market.

Cian Healthcare Headlines

No Headlines